Gilead Sciences Plummets Amid AbbVie Deal With Express Scripts

By: via Benzinga
Shares of Gilead Sciences, Inc. (NASDAQ: GILD) fell over 12 percent in early trading Monday amid news that AbbVie Inc (NYSE: ABBV) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.